CYPRIUM THERAPEUTICS
  • home
  • ABOUT
    • Leadership
  • PIPELINE
    • About Menkes Disease
    • ZYCUBO® (formerly CUTX-101) (Copper Histidinate)
    • AAV-ATP7A Gene Therapy Development Pathway
    • Publications
    • Expanded Access Policy
  • Business Development
  • Investors & Media
    • Press Releases
    • Corporate Presentation
    • Resources
  • CONTACT US

Resources

Forms will be updated on a quarterly basis for the monthly dividends.

Form 8937 – October 31, 2025, November 30, 2025 and December 31, 2025

Form 8937 – July 31, 2025, August 31, 2025 and September 30, 2025

Form 8937 – April 30, 2025, May 31, 2025 and June 30, 2025

Form 8937 – January 31, 2025, February 28, 2025 and March 31, 2025

Corrected Final 2024 Form 8937

Corrected Final 2023 Form 8937

Corrected Final 2022 Form 8937

Corrected Final 2021 Form 8937

Corrected Final 2020 Form 8937

 

©2025 Cyprium Therapeutics

Privacy Disclaimer

1111 Kane Concourse, Suite 301 Bay Harbor Islands, FL 33154


Website by Tidal Media Group